Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on therapy for hepatobiliary diseases

K V Kowdley1

  • 1University of Washington School of Medicine in Seattle, USA.

The Nurse Practitioner
|July 1, 1996
PubMed
Summary

Recent advancements in chronic liver disease management include new hepatitis virus identification and targeted therapies like interferon alfa for viral hepatitis. Liver transplantation and minimally invasive endoscopic procedures offer improved outcomes for end-stage liver disease and biliary disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: frequency of surveillance and survival in hepatocellular carcinoma.

Alimentary pharmacology & therapeutics·2018
Same author

Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.

Alimentary pharmacology & therapeutics·2018
Same author

Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.

Alimentary pharmacology & therapeutics·2017
Same author

Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.

Alimentary pharmacology & therapeutics·2016
Same author

Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.

Journal of viral hepatitis·2016
Same author

Editorial: improved understanding of the epidemiology of primary biliary cirrhosis in South Korea.

Alimentary pharmacology & therapeutics·2016

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Chronic liver diseases encompass a range of conditions with significant morbidity.
  • Recent years have seen substantial progress in understanding and treating these diseases.
  • Key developments include novel diagnostics and therapeutic interventions.

Purpose of the Study:

  • To review recent advancements in the diagnosis and therapy of chronic liver diseases.
  • To highlight new treatment modalities for viral and cholestatic liver conditions.
  • To discuss the role of liver transplantation and endoscopic interventions in hepatobiliary disease management.

Main Methods:

  • Review of current literature on hepatobiliary disease diagnosis and treatment.
  • Analysis of emerging therapies for viral hepatitis (B and C) and cholestatic liver diseases.

Related Experiment Videos

  • Evaluation of outcomes for liver transplantation and minimally invasive biliary procedures.

    • Main Results:

    • Identification of new hepatitis viruses (Hepatitis C and E).
    • Effective treatments like interferon alfa for chronic viral hepatitis B and C, improving liver tests in up to 50% of patients.
    • Ursodeoxycholic acid under investigation for cholestatic diseases (primary biliary cirrhosis, primary sclerosing cholangitis).
    • Established efficacy of liver transplantation for end-stage liver disease (1-year survival >80%).
    • Advancements in gallstone treatment (laparoscopic cholecystectomy, dissolution, lithotripsy) and endoscopic retrograde cholangiopancreatography (ERCP) for biliary disorders.

    Conclusions:

    • Significant progress has been made in managing chronic liver diseases.
    • New antiviral therapies and minimally invasive techniques are improving patient outcomes.
    • Timely referral for advanced management, including liver transplantation and endoscopic procedures, is crucial for end-stage and complex hepatobiliary conditions.